Presents a state of the art review of the various insulin preparations, delivery systems, and appropriate treatment regimens for the patient with type 1 diabetes. Continuous subcutaneous insulin infusion, monitoring of glycemic status (including the latest devices for continuous glucose monitoring), and blood glucose data technology for pattern management are reviewed in detail. Glycemic, lipids, and blood pressure goals are presented. Separate chapters are included on epidemiology, pathogenesis, diagnosis, diet, and exercise recommendations, along with management of acute and long-term complications. A new chapter on inpatient management has been added to the new edition.
Steven Edelman, MD, is Professor of Medicine at UCSD; Irl Hirsch, MD, is Professor of Medicine at the University of Washington; and Jeremy Pttus, MD, is Assistant Professor of Medicine at UCSD. All three authors have type 1 diabetes themselves and have dedicated their careers to treating and educating others with diabetes.
Provides detailed guidance to the practicing physician on how and why to implement the new complications-centric approach to the treatment of obesity in their clinical practice.
The rational for approaching obesity as a medical condition requiring intervention to reduce the risk of diabetes, CV events, and other serious diseases is presented, including the importance of understanding the pathophysiologic basis of obesity and the long list of obesity-related comorbidities.
Major medical society obesity management guidelines which have recently been released are incorporated into the book. All currently available anti-obesity medications are covered, including a detailed discussion of the phase 3 clinical trial data for each agent, its mechanism of action, adverse events and contraindications, and drug prescribing information.
Diagnosis and Management of Type 2 Diabetes 13E provides a practical, concise guide to the management of type 2 diabetes. All available oral and injectable anti-diabetic agents are reviewed in the book with separate chapters for each class of oral agents, insulin therapy, and glucoregulatory hormones. Key clinical trial data on each of the available agents is presented in detail, along with current prescribing guidelines and CV safety and benefit trial data. The book contains a treatment algorithm for initial treatment of type 2 diabetes. Nonpharmacologic measures, treatment of micro- and macrovascular complications, and a review of the diabetes prevention trials are also presented in the book.